Prevalence and age distribution of human papillomavirus infection in a population of Inuit women in Nunavik, Quebec

Cancer Epidemiology Biomarkers and Prevention

Volumn 17, Issue 11, 2008, Pages 3141-3149

  Hamlin Douglas, Lauren Kay ^a   Coutlée, François ^a,b   Roger, Michel ^b,c   Franco, Eduardo L ^a   Brassard, Paul ^a,d  

^a MCGILL UNIVERSITY   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

^c CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^d Division of Clinical Epidemiology   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA;

ADULT; AGE DISTRIBUTION; ARTICLE; CANADA; CANCER RISK; ESKIMO; FEMALE; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MIXED INFECTION; PAPANICOLAOU TEST; PAPILLOMA VIRUS; PREVALENCE; PRIORITY JOURNAL; SQUAMOUS CELL; UTERINE CERVIX CANCER; UTERINE CERVIX CYTOLOGY; UTERINE CERVIX DISEASE; VIRUS INFECTION;

EID: 55849098571     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-08-0625     Document Type: Article

References (29)

1. IARC Working Group. Human papillomaviruses. IARC Monographs on the evaluation of carcinogenic risks to humans. Lyon (France): IARC; 1995. p. 277-82.
2. Clifford GM, Smith JS, Plummer M, Munoz N, Franceschi S. Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis. Br J Cancer 2003;88:63-73.
3. Munoz N, Bosch FX, de Sanjose S, et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 2003;348:518-27.
4. Walboomers JM, Jacobs MV, Manos MM, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999;189:12-9.
5. Clifford GM, Gallus S, Herrero R, et al. Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: a pooled analysis. Lancet 2005;366:991-8.
6. Public Health Agency of Canada. Cervical cancer screening in Canada: 1998 surveillance report. Ottawa: Canada; 1998.
7. Cancer Surveillance On-line [database on the Internet]. Ottawa, Canada: Public Health Agency of Canada. c1992-2004 [updated 2006 Dec 18; cited 2008 June 19]. Available from: http://dsol-smed.hc-sc.gc.ca/dsol-smed/cancer/index.html.
8. National Cancer Institute of Canada. Canadian cancer statistics 1991. Toronto (Canada): 1991.
9. Henry MR. The Bethesda System 2001: an update of new terminology for gynecologic cytology. Clin Lab Med 2003;23:585-603.
10. Tarkowski TA, Rajeevan MS, Lee DR, Unger ER. Improved detection of viral RNA isolated from liquid-based cytology samples. Mol Diagn 2001;6:125-30.
11. Gravitt PE, Peyton CL, Alessi TQ, et al. Improved amplification of genital human papillomaviruses. J Clin Microbiol 2000;38:357-61.
12. Trottier H, Mahmud S, Costa MC, et al. Human papillomavirus infections with multiple types and risk of cervical neoplasia. Cancer Epidemiol Biomarkers Prev 2006;15:1274-80.
13. Rothman KJ. Epidemiology: an introduction. New York: Oxford University Press; 2002.
14. Franco EL, Villa LL, Sobrinho JP, et al. Epidemiology of acquisition and clearance of cervical human papillomavirus infection in women from a high-risk area for cervical cancer. J Infect Dis 1999;180:1415-23.
15. Louchini R, Chateau-Degat ML, Brassard P, Dewailly E. Cervical cancer and cervical intraepithelial neoplasia prevalence among Inuit women in Nunavik, 2005, Quebec, Canada. 24th International Papillomavirus Conference; November 3-9, 2007; Beijing, China; November 3-9, 2007.
16. Herrero R, Hildesheim A, Bratti C, et al. Population-based study of human papillomavirus infection and cervical neoplasia in rural Costa Rica. J Natl Cancer Inst 2000;92:464-74.
17. Richardson H, Kelsall G, Tellier P, et al. The natural history of type-specific human papillomavirus infections in female university students. Cancer Epidemiol Biomarkers Prev2003;12:485-90.
18. Young TK, McNicol P, Beauvais J. Factors associated with human papillomavirus infection detected by polymerase chain reaction among urban Canadian aboriginal and non-aboriginal women. Sex Transm Dis 1997;24:293-8.
19. Sellors JW, Mahony JB, Kaczorowski J, et al. Prevalence and predictors of human papillomavirus infection in women in Ontario, Canada. Survey of HPV in Ontario Women (SHOW) Group. CMAJ 2000;163:503-8.
20. Brown D. HPV type 6/11/16/18 vaccine: first analysis of cross-protection against persistent infection, cervical intraepithelial neoplasia (CIN), and adenocarcinoma in situ (AIS) caused by oncogenic HPV types in addition to 16/18. 47th Interscience Conference on Animicrobial Agents and Chemotherapy; September 17-20, 2007.
21. Harper DM, Franco EL, Wheeler CM, et al. Sustained efficacy up to 4.5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial. Lancet 2006;367:1247-55.
22. Healey SM, Aronson KJ, Mao Y, et al. Oncogenic human papillomavirus infection and cervical lesions in aboriginal women of Nunavut, Canada. Sex Transm Dis 2001;28:694-700.
23. Molano M, Posso H, Weiderpass E, et al. Prevalence and determinants of HPV infection among Colombian women with normal cytology. Br J Cancer 2002;87:324-33.
24. Klug SJ, Hukelmann M, Hollwitz B, et al. Prevalence of human papillomavirus types in women screened by cytology in Germany. J Med Virol 2007;79:616-25.
25. van der Graaf Y, Molijn A, Doornewaard H, Quint W, van Doorn LJ, van den Tweel J. Human papillomavirus and the long-term risk of cervical neoplasia. Am J Epidemiol 2002;156:158-64.
26. Lazcano-Ponce E, Herrero R, Munoz N, et al. Epidemiology of HPV infection among Mexican women with normal cervical cytology. Int J Cancer 2001;91:412-20.
27. Gostout BS, Podratz KC, McGovern RM, Persing DH. Cervical cancer in older women: a molecular analysis of human papillomavirus types, HLA types, and p53 mutations. Am J Obstet Gynecol 1998;179:56-61.
28. Ginaldi L, De Martinis M, D'Ostilio A, et al. The immune system in the elderly: II. Specific cellular immunity. Immunol Res 1999;20:109-15.
29. Castle PE, Jeronimo J, Schiffman M, et al. Age-related changes of the cervix influence human papillomavirus type distribution. Cancer Res 2006;66:1218-24.